Polarityte Inc (NASDAQ:PTE) has earned a consensus recommendation of “Buy” from the eight brokerages that are presently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and five have given a buy recommendation to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $34.33.
Several equities research analysts have commented on the company. Piper Jaffray Companies assumed coverage on Polarityte in a research report on Thursday, December 20th. They issued an “overweight” rating on the stock. Cantor Fitzgerald set a $65.00 price objective on Polarityte and gave the stock a “buy” rating in a research report on Monday, April 8th. Northland Securities reiterated a “buy” rating and set a $50.00 target price on shares of Polarityte in a research report on Monday, March 11th. Zacks Investment Research downgraded Polarityte from a “hold” rating to a “sell” rating in a research note on Saturday, January 19th. Finally, Evercore ISI started coverage on Polarityte in a research note on Wednesday, March 20th. They issued an “outperform” rating and a $26.00 price objective for the company.
A hedge fund recently bought a new stake in Polarityte stock. Comprehensive Portfolio Management LLC bought a new position in Polarityte Inc (NASDAQ:PTE) in the first quarter, according to its most recent disclosure with the SEC. The firm bought 21,702 shares of the company’s stock, valued at approximately $232,000. Comprehensive Portfolio Management LLC owned about 0.10% of Polarityte as of its most recent SEC filing. 54.85% of the stock is owned by institutional investors and hedge funds.
Polarityte stock opened at $8.44 on Friday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 13.76 and a current ratio of 13.80. Polarityte has a 12 month low of $8.19 and a 12 month high of $41.22. The company has a market capitalization of $186.44 million, a price-to-earnings ratio of -1.74 and a beta of 1.48.
Polarityte (NASDAQ:PTE) last released its quarterly earnings data on Monday, January 14th. The company reported ($0.96) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($1.02) by $0.06. Polarityte had a negative return on equity of 258.52% and a negative net margin of 4,259.44%. The business had revenue of $1.13 million for the quarter, compared to analyst estimates of $0.80 million. Sell-side analysts expect that Polarityte will post -4.14 earnings per share for the current year.
PolarityTE, Inc, a biotechnology and regenerative biomaterials company, focuses on discovering, designing, and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine and Contract Services.
Further Reading: What is the 52-week high/low?
Receive News & Ratings for Polarityte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polarityte and related companies with MarketBeat.com's FREE daily email newsletter.